Florida Retina Consultants
Lakeland, Florida 33805
3 studies enrolling now · 30 studies all time
What they study most
Age-related Macular Degeneration (AMD), Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Macular Edema(DME), Diabetic Retinopathy, Full-thickness Macular Holes (MH), Geographic Atrophy (GA), Macular Degeneration, Macular Neovascularization Secondary to Age-Related Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration (AMD), Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration
Studies at this site
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated — Recruiting now
- Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — Recruiting now
- A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
- A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy — Running, not enrolling
- Fenofibrate for Prevention of DR Worsening — Running, not enrolling
- 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
- Evaluation of Tonabersat for DME — Running, not enrolling
- A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Running, not enrolling
- A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — Completed
- Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration — Completed
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling
- Non-proliferative Diabetic Retinopathy Treated With Runcaciguat — Completed
- A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy — Completed
- A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
- DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
- A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment — Completed
- Anti-VEGF Treatment for Prevention of PDR/DME — Completed
- Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
- Effects of Pneumatic Vitreolysis on Macular Hole — Completed
- Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
- Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
- PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
- Treatment for CI-DME in Eyes With Very Good VA Study — Completed
- A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
- The Study to YD312 Tablet in Patients With Diabetic Macular Edema — Status unconfirmed
- Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
- A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors — Completed
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed